New study aims to shield vulnerable groups from COVID-19
NCT ID NCT05556720
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether extra COVID-19 vaccine doses are safe and work well for people with weakened immune systems, such as those with HIV, organ transplants, or blood cancers. Around 960 participants will receive different booster schedules to see which one boosts their protection best. The goal is to find the best way to keep these high-risk individuals safe from severe COVID-19.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Alfred Health
Melbourne, Victoria, 3004, Australia
-
Austin Hospital
Heidelberg, Victoria, 3084, Australia
-
Monash Medical Centre
Clayton, Victoria, 3168, Australia
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Prince Of Wales Hospital
Randwick, New South Wales, 2031, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Royal Brisbane and Womens Hospital
Herston, Queensland, 4029, Australia
-
Royal Melbourne Hospital
Melbourne, Victoria, 3000, Australia
-
St Vincents Hospital
Darlinghurst, New South Wales, Australia
-
St Vincents Hospital
Fitzroy, Victoria, 3065, Australia
-
University Geelong Hospital
Geelong, Victoria, 3220, Australia
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a gentler chemo-radiation combo make stem cell transplants safer for blood cancers?
- Small cash rewards may keep HIV-positive mothers in treatment — a trial puts the idea to the test
- Can a cancer drug reboot the immune system after a stem cell transplant?
- Rare childhood bone lymphoma: can past cases guide future care?
- Choice may boost HIV prevention: a trial tests offering multiple PrEP options to young women in kenya
- A One-Shot gene therapy could take on incurable blood cancer